标准化团队诊疗改善心源性休克结局并建立风险评分
该观察性研究纳入204例连续心源性休克患者,评估标准化团队诊疗是否改善结局及风险评分能否指导决策。结果显示30天生存率从2016年47%升至2017年57.9%和2018年76.6%(p<0.01),并建立基于年龄、糖尿病、透析、升压药使用时长、乳酸、CPO和PAPi的三分类风险评分。
要点
- 标准化团队诊疗可能改善心源性休克患者30天生存率。
- 24小时乳酸≥3.0 mg/dl、CPO<0.6 W、PAPi<1.0为独立预测因素。
- 三分类风险评分(0-1低、2-4中、≥5高)可量化风险并指导决策。
核心结论
- 标准化团队诊疗可能改善心源性休克结局。
- 纳入人口学、实验室和血流动力学数据的评分可量化风险并指导各表型心源性休克的临床决策。
研究设计与样本
- 观察性研究,纳入204例连续心源性休克患者,评估病因、人口学特征、右心导管、机械循环支持使用和生存。
- 在基线及诊断后24小时测量心脏功率输出(CPO)和肺动脉搏动指数(PAPi),并确定24小时乳酸、CPO和PAPi阈值。
- 使用逻辑回归分析开发验证风险分层评分。
主要发现
- 30天生存率2016年为47%,2017年为57.9%,2018年为76.6%(p<0.01)。
- 30天死亡的独立预测因素包括年龄≥71岁、糖尿病、透析、诊断时升压药使用≥36小时、乳酸≥3.0 mg/dl、24小时CPO<0.6 W和PAPi<1.0。
- 每个变量赋1或2分,形成三分类风险评分:0-1分低危、2-4分中危、≥5分高危。
关键数值与推荐
- 24小时阈值:乳酸<3.0 mg/dl、CPO>0.6 W、PAPi>1.0。
- 风险评分变量及赋分:年龄≥71岁、糖尿病、透析、升压药使用≥36小时、乳酸≥3.0 mg/dl、CPO<0.6 W、PAPi<1.0,各赋1或2分。
- 风险分类:0-1分低危、2-4分中危、≥5分高危。
临床怎么用
- 可采用标准化团队诊疗模式管理心源性休克患者。
- 利用24小时乳酸、CPO和PAPi等指标评估风险。
- 应用三分类风险评分辅助临床决策。
局限性
- 为观察性研究,提示标准化团队诊疗可能改善结局,不能确立因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiogenic shock (CS) is a multifactorial, hemodynamically complex syndrome associated with high mortality. Despite advances in reperfusion and mechanical circulatory support, management remains highly variable and outcomes poor. OBJECTIVES: This study investigated whether a standardized team-based approach can improve outcomes in CS and whether a risk score can guide clinical decision making. METHODS: A total of 204 consecutive patients with CS were identified. CS etiology, patient demographic characteristics, right heart catheterization, mechanical circulatory support use, and survival were determined. Cardiac power output (CPO) and pulmonary arterial pulsatility index (PAPi) were measured at baseline and 24 h after the CS diagnosis. Thresholds at 24 h for lactate (<3.0 mg/dl), CPO (>0.6 W), and PAPi (>1.0) were determined. Using logistic regression analysis, a validated risk stratification score was developed. RESULTS: Compared with 30-day survival of 47% in 2016, 30-day survival in 2017 and 2018 increased to 57.9% and 76.6%, respectively (p < 0.01). Independent predictors of 30-day mortality were age ≥71 years, diabetes mellitus, dialysis, ≥36 h of vasopressor use at time of diagnosis, lactate levels ≥3.0 mg/dl, CPO <0.6 W, and PAPi <1.0 at 24 h after diagnosis and implementation of therapies. Either 1 or 2 points were assigned to each variable, and a 3-category risk score was determined: 0 to 1 (low), 2 to 4 (moderate), and ≥5 (high). CONCLUSIONS: This observational study suggests that a standardized team-based approach may improve CS outcomes. A score incorporating demographic, laboratory, and hemodynamic data may be used to quantify risk and guide clinical decision-making for all phenotypes of CS.
引用
- Tehrani BN, Truesdell AG, Sherwood MW, et al. Standardized Team-Based Care for Cardiogenic Shock. J Am Coll Cardiol. 2019. PMID: 30947919. doi:10.1016/j.jacc.2018.12.084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。